The five-year agreement will allow researchers from both organizations to not only work together to share and develop research that will improve the health of the population, but will also create new — or improve existing — methods and ways of conducting research. Scientists will be able to work together and build on research opportunities in areas related to biosafety, pharmaceutical and cosmetic research.
“The main goal of the agreement with NANOTEC is to work together and share research for the benefit of healthcare,” Patricia Chase, Ph.D., dean of the WVU School of Pharmacy, said. “If you want to change the world and make everyone healthier by providing quality healthcare and treatments, you must start with research.”
The partnership will also open a pathway of communication between researchers to share information about other research projects, thereby reducing the potential of duplicate research efforts.
The WVU School of Pharmacy and NANOTEC have worked together sharing research information in the past informally, but the agreement now makes the work between the two organizations part of a formal partnership and opens the doors to new opportunities.
Yon Rojanasakul, Ph.D., professor in the Department of Basic Pharmaceutical Sciences, will be the School’s chief liaison with NANOTEC.
(l-r) Dr. Yon Rojanasakul and Dr. Patricia Chase of the WVU School of Pharmacy; Euaporn Ratnabhanu, acting executive director of NANOTEC; and Dr. Sirasak Teparkum, deputy executive director of NANOTEC
For more information: Amy Newton, HSC News Service, 304-293-7087